PMC:7441777 / 49529-51434
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T105 | 295-298 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T77 | 71-79 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T78 | 82-91 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T79 | 263-271 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T80 | 827-835 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 1258-1266 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T82 | 1536-1544 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T83 | 1763-1771 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T84 | 1884-1892 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T85 | 1895-1904 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T324 | 42-43 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T325 | 120-121 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T326 | 165-166 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T327 | 510-513 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T328 | 1187-1188 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T329 | 1490-1491 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T46875 | 26-36 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T22320 | 194-205 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T80937 | 221-230 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T24344 | 341-352 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T98962 | 499-503 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T71966 | 552-562 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T90398 | 569-578 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T23792 | 585-598 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T42245 | 616-626 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T90588 | 728-730 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T93177 | 861-872 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T65194 | 1067-1073 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T29242 | 1126-1128 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T73139 | 1153-1157 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T70168 | 1230-1234 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T25385 | 1235-1245 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T98626 | 1459-1463 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T66579 | 1711-1722 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T46661 | 1744-1754 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T39 | 295-310 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
T40 | 810-819 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1524 | 21-25 | Gene | denotes | RdRp | Gene:43740578 |
1525 | 274-278 | Gene | denotes | RdRp | Gene:43740578 |
1526 | 494-498 | Gene | denotes | RdRp | Gene:43740578 |
1527 | 505-509 | Gene | denotes | RdRp | Gene:43740578 |
1528 | 515-519 | Gene | denotes | RdRp | Gene:43740578 |
1529 | 526-530 | Gene | denotes | RdRp | Gene:43740578 |
1530 | 531-535 | Gene | denotes | TF2b | Gene:2959 |
1531 | 537-541 | Gene | denotes | RdRp | Gene:43740578 |
1532 | 547-551 | Gene | denotes | RdRp | Gene:43740578 |
1533 | 564-568 | Gene | denotes | RdRp | Gene:43740578 |
1534 | 580-584 | Gene | denotes | RdRp | Gene:43740578 |
1535 | 611-615 | Gene | denotes | RdRp | Gene:43740578 |
1536 | 1165-1169 | Gene | denotes | TF2b | Gene:2959 |
1537 | 1269-1273 | Gene | denotes | RdRp | Gene:43740578 |
1538 | 1471-1475 | Gene | denotes | TF2b | Gene:2959 |
1539 | 1524-1528 | Gene | denotes | RdRp | Gene:43740578 |
1540 | 838-842 | Gene | denotes | RdRp | Gene:43740578 |
1541 | 1774-1778 | Gene | denotes | RdRp | Gene:43740578 |
1542 | 263-273 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1543 | 827-837 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1544 | 1258-1268 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1545 | 1536-1546 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1546 | 1763-1773 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1547 | 194-205 | Chemical | denotes | polyphenols | MESH:D059808 |
1548 | 341-352 | Chemical | denotes | polyphenols | MESH:D059808 |
1549 | 616-626 | Chemical | denotes | remdesivir | MESH:C000606551 |
1550 | 861-872 | Chemical | denotes | polyphenols | MESH:D059808 |
1551 | 1129-1133 | Chemical | denotes | PBSA | MESH:C437084 |
1552 | 1153-1157 | Chemical | denotes | EGCG | MESH:C045651 |
1553 | 1235-1245 | Chemical | denotes | remdesivir | MESH:C000606551 |
1554 | 1306-1310 | Chemical | denotes | ADME | |
1555 | 1459-1463 | Chemical | denotes | EGCG | MESH:C045651 |
1556 | 1711-1722 | Chemical | denotes | polyphenols | MESH:D059808 |
1557 | 71-91 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1558 | 1323-1331 | Disease | denotes | toxicity | MESH:D064420 |
1559 | 1884-1904 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T16 | 510-513 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T522 | 0-311 | Sentence | denotes | Keeping in mind that RdRp inhibitors play a crucial role to combat the SARS-CoV-2 infection, in this work, we performed a comprehensive molecular docking study with a library of hundred natural polyphenols with potential antiviral properties that may inhibit the SARS-CoV-2 RdRp and prevent the RNA replication. |
T523 | 312-431 | Sentence | denotes | We shortlisted eight natural polyphenols having binding energy −7.0 kcal/mol or less for molecular dynamics simulation. |
T524 | 432-773 | Sentence | denotes | Further, we performed 150 ns molecular dynamics simulation of RdRp/EGCG, RdRp/TF1, RdRp/TF2a, RdRp/TF2b, RdRp/TF3, RdRp/hesperidin, RdRp/myricetin, RdRp/quercetagetin, along with RdRp/remdesivir complex and computed the binding energies by the molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) scheme from last 50 ns trajectories. |
T525 | 774-994 | Sentence | denotes | Our study suggests that the complex formation of the SARS-CoV-2 RdRp and eight natural polyphenols is favoured by the intermolecular van der Waals and electrostatic interactions as well as nonpolar solvation free energy. |
T526 | 995-1082 | Sentence | denotes | We have also investigated the hotspot residues controlling the receptor-ligand binding. |
T527 | 1083-1274 | Sentence | denotes | Finally, molecular dynamics simulation and MM-PBSA study reveals that EGCG, TF2a, TF2b, and TF3 possess a better binding affinity than the control drug remdesivir against the SARS-CoV-2 RdRp. |
T528 | 1275-1415 | Sentence | denotes | Further, we also looked at the ADME prediction, toxicity prediction, and target analysis to assess their druggability of the five compounds. |
T529 | 1416-1590 | Sentence | denotes | The obtained results strongly suggest that EGCG, TF2a, TF2b, and TF3 have a stable binding affinity towards RdRp of the SARS-CoV-2 with favourable pharmacokinetic properties. |
T530 | 1591-1664 | Sentence | denotes | These bioactive compounds exhibit broad ranges of therapeutic properties. |
T531 | 1665-1779 | Sentence | denotes | Therefore, we believe that these four natural polyphenols can act as potential inhibitors for the SARS-CoV-2 RdRp. |
T532 | 1780-1905 | Sentence | denotes | However, further in vitro and in vivo studies need to be carried out to validate their efficacy against SARS-CoV-2 infection. |